INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 417m ago
HOUSE PTR16m ago
SEC 13F16m ago
ROBINHOOD CHAIN16m ago
Corporate insider
LJ

Lin Sue-Jean

DirectorCIK 0001867788

EDGAR filingsOpen in network
Disclosed transactions5
Buys / sells0 / 1
Max Insider Score45
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
24
LJ
Lin Sue-JeanDirector
ARQTArcutis Biotherapeutics, Inc.
Option exercise
M$156K
18.1K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Arcutis Biotherapeutics, Inc.Director · Nov 25, 2025
16
LJ
Lin Sue-JeanDirector
ARQTArcutis Biotherapeutics, Inc.
Option exercise
M
$54K
7,220 sh
Nov 24, 2025
Nov 25, 2025
traded Nov 24, 2025
+1d
SEC FORM 4

Evidence

9
LJ
Lin Sue-JeanDirector
ARQTArcutis Biotherapeutics, Inc.
Option exercise
M—
7,220 sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC FORM 4

Evidence

45
LJ
Lin Sue-JeanDirector
ARQTArcutis Biotherapeutics, Inc.
Open-market sale
SELL$778K
25.3K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC FORM 4

Evidence

9
LJ
Lin Sue-JeanDirector
ARQTArcutis Biotherapeutics, Inc.
Option exercise
M—
18.1K sh
Nov 24, 2025Nov 25, 2025
traded Nov 24, 2025
+1dSEC FORM 4

Evidence